Contrastingly, we showed for the first time that partial deletion of the il-4rα gene, specifically, at the chronic stage of schistosomiasis ameliorates the tissue pathology by reducing type-2 immune responses, improving immune balance between T helper cytokines and skewing the diminished immune response towards a more regulatory profile without affecting animal viability. This evidence concerns the gene IL4R and schistosomiasis.